Research theme for competitive and other funds (23):
2014 - 2016 The mechanisms of immune-mediated tumor progression triggered by cancer metabolism
2010 - 2012 Proteomic analysis of phosphorylation in leukemic cells
2010 - 2012 Development of the novel AML treatments by targeting leukemia stem cells
2010 - 2012 Molecular mechanism for self-renewal of cancer stem cells
2010 - 2012 Development of Novel Treatment Strategies Targeting Cancer Stem Cells
2008 - 2012 Molecular basis of the function and generation of Foxp3-expressing regulatory T cells
2007 - 2009 がん幹細胞制御因子を標的とした新しいがん治療法の開発に関する研究
2007 - 2009 転写制御因子を介した造血幹細胞と白血病幹細胞の制御機構の解析
2007 - 2009 Study for regulatory mechanism of normal and leukemic stem cells through transcription factors
2005 - 2009 白血病関連因子AML1複合体の機能解析
2005 - 2009 Functional study of leukemia-associated factor AML1
2003 - 2005 AML1 complex as a molecular target for leukemia therapy
2004 - 2004 AML1及びPMLを分子標的にした白血病治療薬の開発
2002 - 2002 AML1複合体因子の機能解析
2000 - 2002 STUDY OF HISTONE ACETYLATION REGULATION IN LEUKEMOGENESIS
2001 - 2001 複合体精製によるAML1及びp53の機能解析
2000 - 2000 白血病関連融合遺伝子産物の作用におけるヒストンアセチル化制御の解析
1999 - 2000 Histone acetylation and human leukemia
1995 - 1995 細胞分化におけるc-jun遺伝子の発現制御とE1A結合蛋白質p300の機能
1994 - 1994 EIA結合蛋白質p300の生理機能と癌遺伝子c-jumの発現制御機構の解析
Chromatin Function in transcriptional regulation
Differentiation of Hematopoietic cells
Mechanism of Leukemogenesis
Show all
Papers (97):
Ayuna Hattori, Emi Takamatsu-Ichihara, Yoshiki Yamamoto, Shuhei Fujita, Kazutsune Yamagata, Takuo Katsumoto, Yukino Machida, Haruka Shinohara, Ryo Murakami, Issay Kitabayashi. Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia. Leukemia. 2023
Haruka Shinohara, Rie Sawado, Makoto Nakagawa, Ayuna Hattori, Kazutsune Yamagata, Kimiharu Tauchi, Jumpei Ito, Yasumichi Kuwahara, Tsukasa Okuda, Chitose Ogawa, et al. Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors. Molecular therapy oncolytics. 2022. 27. 14-25
Jumpei Ito, Kazutsune Yamagata, Haruka Shinohara, Yutaka Shima, Takuo Katsumoto, Yukiko Aikawa, Issay Kitabayashi. Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1. International Journal of Hematology. 2022. 117. 1. 78-89
Takuo Katsumoto, Yoko Ogawara, Kazutsune Yamagata, Yukiko Aikawa, Ryo Goitsuka, Takuro Nakamura, Issay Kitabayashi. MOZ is critical for the development of MOZ/MLL-fusion-induced leukemia through regulation of Hoxa9/Meis1 expression. Blood Advances. 2022
Makoto Nakagawa, Masayuki Yamaguchi, Makoto Endo, Yukino Machida, Ayuna Hattori, Fumie Tanzawa, Shinji Tsutsumi, Issay Kitabayashi, Akira Kawai, Fumihiko Nakatani. Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma. Journal of Bone Oncology. 2022. 34. 100430-100430
OGOH Honami, YAMAGATA Kazutsune, NAKAO Tomomi, SANDELL Lisa L., YAMAMOTO Ayaka, YAMASHITA Aiko, TANGA Naomi, SUZUKI Mai, ABE Takaya, KITABAYASHI Issay, et al. Deregulation of histone methylation is implicated in the etiology of frontonasal dysplasia. 日本先天異常学会学術集会プログラム・抄録集. 2019. 59th
Kazutsune Yamagata, Mariko Saito, Mai Suzuki, Takuo Katsumoto, Honami Ogoh, Toshio Watanabe, Issay Kitabayashi. AF10 links histone chaperones Supt6h and FACT complex to MLL-fusion leukemia. CANCER SCIENCE. 2018. 109. 1111-1111
2010/04 - 現在 National Cancer Center Research Institute Division of Hematological Malignancy Vice Director/Chief
2002/10 - 2010/03 National Cancer Center Research Institute Molecular Oncology Division Chief
Committee career (1):
日本癌学会 評議委員
Awards (2):
2002 - 日本癌学会奨励賞
Japanese Cancer Association JCA-Mauvernay Award Molecular study of acute myeloid leukemia and its application for therapy
Association Membership(s) (8):
米国血液学会
, 日本血液学会
, 日本分子生物学会
, 日本癌学会
, The Japanese Society of Hematology
, The American Society of Hematology
, The Molecular Biology Society of Japan
, The Japanese Cancer Association